Immunotherapy for Nasopharyngeal Carcinoma: The Earlier the Better

JAMA. 2023 Nov 28;330(20):1954-1955. doi: 10.1001/jama.2023.22465.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Immunological* / therapeutic use
  • Humans
  • Immunotherapy / methods
  • Nasopharyngeal Carcinoma* / drug therapy
  • Nasopharyngeal Carcinoma* / therapy
  • Nasopharyngeal Neoplasms* / drug therapy
  • Nasopharyngeal Neoplasms* / therapy
  • Time-to-Treatment

Substances

  • Antineoplastic Agents, Immunological